Antipodes Partners LTD Merck & Co., Inc. Transaction History

Antipodes Partners LTD

$2.83 Billion
Q3 2024

A detailed history of Antipodes Partners LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Antipodes Partners LTD holds 1,575,816 shares of MRK stock, worth $156 Million. This represents 6.33% of its overall portfolio holdings.

Number of Shares

1,575,816

Previous 1,675,646 5.96%

Holding current value

$156 Million

Previous $207 Million 13.74%

% of portfolio

6.33%

Previous 7.64%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$111.15 - $128.97 $11.1 Million - $12.9 Million	-99,830 Reduced 5.96%	1,575,816 $179 Million
Q2 2024 Aug 05, 2024	SELL	$123.8 - $132.96 $26.5 Million - $28.4 Million	-213,659 Reduced 11.31%	1,675,646 $207 Million
Q1 2024 May 06, 2024	SELL	$113.24 - $131.95 $32.3 Million - $37.7 Million	-285,599 Reduced 13.13%	1,889,305 $249 Million
Q4 2023 Jan 24, 2024	SELL	$100.18 - $109.02 $9.53 Million - $10.4 Million	-95,095 Reduced 4.19%	2,174,904 $237 Million
Q3 2023 Nov 09, 2023	BUY	$102.95 - $114.33 $53.6 Million - $59.5 Million	520,841 Added 29.78%	2,269,999 $237 Million
Q2 2023 Jul 25, 2023	SELL	$108.61 - $118.38 $11.7 Million - $12.7 Million	-107,402 Reduced 5.79%	1,749,158 $202 Million
Q1 2023 May 11, 2023	BUY	$102.94 - $114.86 $115,395 - $128,758	1,121 Added 0.06%	1,856,560 $198 Million
Q4 2022 Feb 08, 2023	SELL	$87.44 - $112.11 $35.8 Million - $45.9 Million	-409,457 Reduced 18.08%	1,855,439 $206 Million
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $26.7 Million - $30 Million	316,431 Added 16.24%	2,264,896 $195 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $20 Million - $22.6 Million	-239,177 Reduced 10.93%	1,948,465 $178 Million
Q1 2022 Apr 21, 2022	BUY	$73.51 - $82.4 $16.3 Million - $18.3 Million	222,174 Added 11.3%	2,187,642 $179 Million
Q4 2021 Apr 21, 2022	SELL	$72.28 - $90.54 $384,601 - $481,763	-5,321 Reduced 0.27%	1,965,468 $151 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $4.94 Million - $6.18 Million	68,277 Added 3.59%	1,970,789 $161 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $11.1 Million - $12.2 Million	-154,947 Reduced 7.53%	1,902,512 $143 Million
Q2 2021 Aug 17, 2021	BUY	$70.31 - $77.77 $1.73 Million - $1.92 Million	24,642 Added 1.21%	2,057,459 $160 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $7.12 Million - $8.39 Million	103,441 Added 5.36%	2,032,817 $157 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $13.9 Million - $15.4 Million	193,495 Added 11.15%	1,929,376 $158 Million
Q3 2020 Nov 10, 2020	SELL	$73.18 - $82.95 $11.3 Million - $12.8 Million	-154,012 Reduced 8.15%	1,735,881 $144 Million
Q2 2020 Jul 30, 2020	BUY	$70.42 - $80.13 $2.63 Million - $2.99 Million	37,302 Added 2.01%	1,889,893 $146 Million
Q1 2020 May 07, 2020	BUY	$63.36 - $87.82 $117 Million - $163 Million	1,852,591 New	1,852,591 $143 Million
Q4 2019 Feb 05, 2020	SELL	$77.58 - $87.54 $137 Million - $155 Million	-1,768,365 Closed	0 $0
Q3 2019 Nov 06, 2019	BUY	$76.08 - $82.93 $23.1 Million - $25.2 Million	303,391 Added 20.71%	1,768,365 $149 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $102 Million - $120 Million	1,464,974 New	1,464,974 $0

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Antipodes Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Antipodes Partners LTD with notifications on news.

Account

Antipodes Partners LTD Merck & Co., Inc. Transaction History